Literature DB >> 10840050

Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.

J Wijnholds1, C A Mol, L van Deemter, M de Haas, G L Scheffer, F Baas, J H Beijnen, R J Scheper, S Hatse, E De Clercq, J Balzarini, P Borst.   

Abstract

Two prominent members of the ATP-binding cassette superfamily of transmembrane proteins, multidrug resistance 1 (MDR1) P-glycoprotein and multidrug resistance protein 1 (MRP1), can mediate the cellular extrusion of xenobiotics and (anticancer) drugs from normal and tumor cells. The MRP subfamily consists of at least six members, and here we report the functional characterization of human MRP5. We found resistance against the thiopurine anticancer drugs, 6-mercaptopurine (6-MP) and thioguanine, and the anti-HIV drug 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in MRP5-transfected cells. This resistance is due to an increased extrusion of PMEA and 6-thioinosine monophosphate from the cells that overproduce MRP5. In polarized Madin-Darby canine kidney II (MDCKII) cells transfected with an MRP5 cDNA construct, MRP5 is routed to the basolateral membrane and these cells transport S-(2,4-dinitrophenyl)glutathione and glutathione preferentially toward the basal compartment. Inhibitors of organic anion transport inhibit transport mediated by MRP5. We speculate that MRP5 might play a role in some cases of unexplained resistance to thiopurines in acute lymphoblastic leukemia and/or to antiretroviral nucleoside analogs in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840050      PMCID: PMC16570          DOI: 10.1073/pnas.120159197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication.

Authors:  V M Pisarev; S H Lee; M C Connelly; A Fridland
Journal:  Mol Pharmacol       Date:  1997-07       Impact factor: 4.436

2.  Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

Authors:  M Kool; M de Haas; G L Scheffer; R J Scheper; M J van Eijk; J A Juijn; F Baas; P Borst
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

3.  Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database.

Authors:  R Allikmets; B Gerrard; A Hutchinson; M Dean
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

4.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

Review 5.  Structural, mechanistic and clinical aspects of MRP1.

Authors:  D R Hipfner; R G Deeley; S P Cole
Journal:  Biochim Biophys Acta       Date:  1999-12-06

6.  The multidrug resistance protein family.

Authors:  P Borst; R Evers; M Kool; J Wijnholds
Journal:  Biochim Biophys Acta       Date:  1999-12-06

Review 7.  The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression.

Authors:  T Ishikawa; Z S Li; Y P Lu; P A Rea
Journal:  Biosci Rep       Date:  1997-04       Impact factor: 3.840

8.  Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.

Authors:  G Jedlitschky; I Leier; U Buchholz; K Barnouin; G Kurz; D Keppler
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

9.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.

Authors:  D W Loe; K C Almquist; R G Deeley; S P Cole
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

View more
  100 in total

Review 1.  Role of red blood cells in pharmacokinetics of chemotherapeutic agents.

Authors:  Dirk Schrijvers
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

Authors:  Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 3.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

4.  Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5).

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Stephen B Hladky; Suresh V Ambudkar; Margery A Barrand
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

Review 5.  Mode of action of microbial bioactive metabolites.

Authors:  V Bethal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

6.  Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.

Authors:  Laurence Bousquet; Alain Pruvost; Anne-Cécile Guyot; Robert Farinotti; Aloïse Mabondzo
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

Review 7.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

8.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.

Authors:  Glen Reid; Peter Wielinga; Noam Zelcer; Ingrid van der Heijden; Annemieke Kuil; Marcel de Haas; Jan Wijnholds; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

9.  The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes.

Authors:  Omar Janneh; Andrew Owen; Patrick G Bray; David J Back; Munir Pirmohamed
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

10.  Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance.

Authors:  Marek Kucka; Karla Kretschmannova; Takayo Murano; Chung-Pu Wu; Hana Zemkova; Suresh V Ambudkar; Stanko S Stojilkovic
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.